Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hyperthermia × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Penile Neoplasms 2 Osteosarcoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Burkitt Lymphoma 2 Wilms Tumor 1 Vascular Neoplasms 1 Teratoma 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Pleuropulmonary blastoma 1 Neurofibrosarcoma 1 Neuroblastoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasm Metastasis 1 Myoepithelioma 1 Lymphoma, Follicular 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Diathermy 7 Radiotherapy 5 Surgical Procedures, Operative 2 Drug Therapy 2 tislelizumab 1 anlotinib 1 Solutions 1 Patient Reported Outcome Measures 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Folfox protocol 1 Fluorouracil 1 Doxorubicin 1 Dacarbazine 1 Consolidation Chemotherapy 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡